Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Spondyloarthritis Related to Crohn's Disease
NCT00972218Phase 4Withdrawn
- Sponsor
- University of Alberta
- Start
- Jul 2009
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in Enteropathic spondyloarthritis (EnSpA), sponsored by University of Alberta. Planned start Jul 2009; status: withdrawn.
02
Drugs
03
Conditions
Enteropathic spondyloarthritis (EnSpA)
Beyond the preview
Go deeper on NCT00972218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972218.